BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18621970)

  • 1. Pharmacogenetic study of 5,10-methylenetetrahydrofolate reductase C677T and thymidylate synthase 3R/2R gene polymorphisms and methotrexate-related toxicity in Chinese Han patients with inflammatory arthritis.
    Zeng QY; Wang YK; Xiao ZY; Chen SB
    Ann Rheum Dis; 2008 Aug; 67(8):1193-4. PubMed ID: 18621970
    [No Abstract]   [Full Text] [Related]  

  • 2. Polymorphisms in the thymidylate synthase and methylenetetrahydrofolate reductase genes and sensitivity to the low-dose methotrexate therapy in patients with rheumatoid arthritis.
    Kumagai K; Hiyama K; Oyama T; Maeda H; Kohno N
    Int J Mol Med; 2003 May; 11(5):593-600. PubMed ID: 12684695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylenetetrahydrofolate reductase (MTHFR) C677T and thymidylate synthase promoter (TSER) polymorphisms in Indonesian children with and without leukemia.
    Giovannetti E; Ugrasena DG; Supriyadi E; Vroling L; Azzarello A; de Lange D; Peters GJ; Veerman AJ; Cloos J
    Leuk Res; 2008 Jan; 32(1):19-24. PubMed ID: 17395259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Markers of Therapeutic Efficacy of Methotrexate in Patients with Psoriasis.
    Voron'ko OE; Baskaev KK; Sobolev VV; Denisova EV; Korsunskaya IM
    Bull Exp Biol Med; 2022 Feb; 172(4):460-463. PubMed ID: 35175470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of hyperhomocysteinemia with genetic variants in key enzymes of homocysteine metabolism and methotrexate toxicity in rheumatoid arthritis patients.
    Chaabane S; Messedi M; Akrout R; Ben Hamad M; Turki M; Marzouk S; Keskes L; Bahloul Z; Rebai A; Ayedi F; Maalej A
    Inflamm Res; 2018 Aug; 67(8):703-710. PubMed ID: 29796841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Determinants of Methotrexate Toxicity in Tunisian Patients with Rheumatoid Arthritis: A Study of Polymorphisms Involved in the MTX Metabolic Pathway.
    Chaabane S; Marzouk S; Akrout R; Ben Hamad M; Achour Y; Rebai A; Keskes L; Fourati H; Bahloul Z; Maalej A
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):385-93. PubMed ID: 26077125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetic study of methylenetetrahydrofolate reductase and thymidylate synthase in Japanese and assessment of ethnic and gender differences.
    Inoue S; Hashiguchi M; Chiyoda T; Sunami Y; Tanaka T; Mochizuki M
    Pharmacogenomics; 2007 Jan; 8(1):41-7. PubMed ID: 17187508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic determinants of methotrexate toxicity in rheumatoid arthritis patients: a study of polymorphisms affecting methotrexate transport and folate metabolism.
    Bohanec Grabar P; Logar D; Lestan B; Dolzan V
    Eur J Clin Pharmacol; 2008 Nov; 64(11):1057-68. PubMed ID: 18607581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are Thymidylate synthase and Methylene tetrahydrofolate reductase genes linked with methotrexate response (efficacy, toxicity) in Indian (Asian) rheumatoid arthritis patients?
    Ghodke Y; Chopra A; Joshi K; Patwardhan B
    Clin Rheumatol; 2008 Jun; 27(6):787-9. PubMed ID: 18274813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms: relationships with 5-fluorouracil sensitivity.
    Etienne MC; Ilc K; Formento JL; Laurent-Puig P; Formento P; Cheradame S; Fischel JL; Milano G
    Br J Cancer; 2004 Jan; 90(2):526-34. PubMed ID: 14735204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between the C677T and A1298C polymorphisms of MTHFR and the efficacy and toxicity of methotrexate in rheumatoid arthritis: a meta-analysis.
    Lee YH; Song GG
    Clin Drug Investig; 2010; 30(2):101-8. PubMed ID: 20067328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms of folate pathway enzymes (methylenetetrahydrofolate reductase and thymidylate synthase) and their relationship with thymidylate synthase expression in human astrocytic tumors.
    da Costa DM; de Lima GP; Faria MH; Rabenhorst SH
    DNA Cell Biol; 2012 Jan; 31(1):57-66. PubMed ID: 21848426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of folate pathway polymorphisms on high-dose methotrexate-related toxicity and survival in childhood acute lymphoblastic leukemia.
    Erčulj N; Kotnik BF; Debeljak M; Jazbec J; Dolžan V
    Leuk Lymphoma; 2012 Jun; 53(6):1096-104. PubMed ID: 22074251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), methionine synthase reductase (MTRR), and thymidylate synthase (TYMS) in multiple myeloma risk.
    Lima CS; Ortega MM; Ozelo MC; Araujo RC; De Souza CA; Lorand-Metze I; Annichino-Bizzacchi JM; Costa FF
    Leuk Res; 2008 Mar; 32(3):401-5. PubMed ID: 17655928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis.
    Ranganathan P; Culverhouse R; Marsh S; Mody A; Scott-Horton TJ; Brasington R; Joseph A; Reddy V; Eisen S; McLeod HL
    J Rheumatol; 2008 Apr; 35(4):572-9. PubMed ID: 18381794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of methylenetetrahydrofolate reductase and thymidylate synthetase gene polymorphisms on lung adenocarcinoma occurrence.
    Cavic M; Krivokuca A; Spasic J; Brotto K; Malisic E; Radosavljevic D; Radulovic S; Jankovic R
    J BUON; 2014; 19(4):1024-8. PubMed ID: 25536611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between methotrexate efficacy & toxicity with C677T polymorphism of the methylenetetrahydrofolate gene in rheumatoid arthritis patients on folate supplementation.
    Aggarwal P; Naik S; Mishra KP; Aggarwal A; Misra R
    Indian J Med Res; 2006 Nov; 124(5):521-6. PubMed ID: 17213520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms on the disease-free survival of breast cancer patients receiving adjuvant 5-fluorouracil/methotrexate-based therapy.
    Paré L; Altés A; Ramón y Cajal T; Del Rio E; Alonso C; Sedano L; Barnadas A; Baiget M
    Anticancer Drugs; 2007 Aug; 18(7):821-5. PubMed ID: 17581305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of the polymorphisms in thymidylate synthase and methylenetetrahydrofolate reductase gene in lung cancer.
    Takehara A; Kawakami K; Ohta N; Oyama K; Ota Y; Oda M; Watanabe G
    Anticancer Res; 2005; 25(6C):4455-61. PubMed ID: 16334126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the methylenetetrahydrofolate reductase C677T polymorphism on chemosensitivity of colon and breast cancer cells to 5-fluorouracil and methotrexate.
    Sohn KJ; Croxford R; Yates Z; Lucock M; Kim YI
    J Natl Cancer Inst; 2004 Jan; 96(2):134-44. PubMed ID: 14734703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.